Story perspectives

FDA Urges Testosterone Access Amid Health Crisis Debate

12/13/2025

Summary

Story summary

A U.S. Food and Drug Administration (FDA) panel urged greater access to testosterone for men, linking low testosterone to weight gain and exhaustion and describing it as a health crisis affecting millions.
Some medical professionals criticized the panel for overlooking risks such as high blood pressure.
The discussion highlighted disparities in access for cisgender men versus transgender individuals and hypocrisy in the federal stance on hormone therapy.

1 of 1

Story summary

A U.S. Food and Drug Administration (FDA) panel urged greater access to testosterone for men, linking low testosterone to weight gain and exhaustion and describing it as a health crisis affecting millions.
Some medical professionals criticized the panel for overlooking risks such as high blood pressure.
The discussion highlighted disparities in access for cisgender men versus transgender individuals and hypocrisy in the federal stance on hormone therapy.